Home / Frovatriptan / United States
US ATC N02CC07 · updated 2 Nov 2026
Frovatriptan shortage in United States
Is there a Frovatriptan shortage in United States?
Yes. As of 2 Nov 2026, 2 Frovatriptan products are reported short in United States, the first since 12 Nov 2025. No return date has been given. Main reason: not stated.
Also short in Italy. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Frova, Tablet, 2.5 mg (NDC 0603-3718-34) discontinuation | Endo Pharmaceuticals, Inc. | 12 Nov 2025 | not given | Not stated |
| US | Frova, Tablet, 2.5 mg (NDC 63481-025-09) discontinuation | Endo Pharmaceuticals, Inc. | 24 Feb 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).